Novartis AG Total Non-Operating Income/Expense 2012-2026 | NVS
Novartis AG total non-operating income/expense for the twelve months ending March 31, 2026 was $-1.432B, a 56.33% increase year-over-year.
- Novartis AG annual total non-operating income/expense for 2025 was $-1.292B, a 42.92% increase from 2024.
- Novartis AG annual total non-operating income/expense for 2024 was $-0.904B, a 39.94% increase from 2023.
- Novartis AG annual total non-operating income/expense for 2023 was $-0.646B, a 15.99% decline from 2022.